PHX: Shoulder Prosthesis, Reverse Configuration

Product code PHX, “Shoulder Prosthesis, Reverse Configuration” in FDA's classification database, is a Class II device type under 21 CFR 888.3660 (shoulder joint metal/polymer semi-constrained cemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 206 clearances under PHX, 173 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
PHX
Regulation
21 CFR 888.3660
Class
II
Panel
Orthopedic
Clearances
206
Most recent
Oct 2, 2026
Median review, last 2 years
128 days
Third-party review
Not eligible
Implant
Yes

What it covers

Intended to be used to relieve pain and to replace the glenoid and humeral side of the shoulder joint in order to restore mobility in a grossly rotator cuff deficient joint with severe arthropathy or a previous joint replacement with a grossly rotator cuff deficient joint.

FDA’s definition of product code PHX, from the Product Classification database.

FDA flags PHX devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K263086AltiVate Reverse® Glenosphere with RAVN™ TechnologyEncore Medical L.P.Oct 2, 2026Special
K260556Veritas Shoulder SystemRestor3DJul 1, 2026Traditional
K261683Augment Off-Axis Instrument SystemZimmer, Inc.Jun 16, 2026Special
K260102Tornier Perform Reversed Glenoid and Tornier Perform Reversed Augmented Glenoid Shoulder SystemStryker Corporation (Tornier, Inc.)Jun 12, 2026Traditional
K261016MSS - Humeral reverse liners extensionMedacta International, SAJun 10, 2026Traditional
K253992Veritas Reverse Total Shoulder SystemRestor3DMay 7, 2026Traditional
K252404Comprehensive Reverse Shoulder - HA Glenosphere BaseplatesBiomet OrthopedicsApr 15, 2026Traditional
K260583Equinoxe® Shoulder SystemExactech, Inc.Apr 14, 2026Traditional
K254128InSet Reverse Total Shoulder SystemShoulder Innovations, Inc.Apr 13, 2026Traditional
K253674Blueprint Patient-Specific InstrumentationStryker Corporation (Tornier, S.A.S.)Apr 3, 2026Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 206 with a free account)

Clearances by year

173 PHX 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)17132
2025972
20249139
20239154
20229198
202121143
202013143
20199144
201814127
201711141
20164132
20154206
201412110
20138143
201212114
20111294

Who submits

39 applicants cleared a PHX device since 2011. 65% of the clearances went to applicants in United States, then France (13%), Switzerland (9%) and Ireland (6%). By type: Traditional 78% and Special 22%.

ApplicantClearances since 2011
Encore Medical L.P.14
Exactech, Inc.14
Medacta International S.A.12
Arthrex, Inc.11
Biomet Manufacturing Corp11
Lima Corporate S.P.A.11
Tornier, Inc.10
Fx Shoulder USA, Inc.9

How FDA classifies it

Class II. The special controls for this device are:

(1) FDA's:

(i) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical Devices—Part I: Evaluation and Testing,’ ”

(ii) “510(k) Sterility Review Guidance of 2/12/90 (K90-1),”

(iii) “Guidance Document for Testing Orthopedic Implants with Modified Metallic Surfaces Apposing Bone or Bone Cement,”

(iv) “Guidance Document for the Preparation of Premarket Notification (510(k)) Application for Orthopedic Devices,” and

(v) “Guidance Document for Testing Non-articulating, ‘Mechanically Locked’ Modular Implant Components,”

(2) International Organization for Standardization's (ISO):

(i) ISO 5832-3:1996 “Implants for Surgery—Metallic Materials—Part 3: Wrought Titanium 6-aluminum 4-vandium Alloy,”

(ii) ISO 5832-4:1996 “Implants for Surgery—Metallic Materials—Part 4: Cobalt-chromium-molybdenum casting alloy,”

(iii) ISO 5832-12:1996 “Implants for Surgery—Metallic Materials—Part 12: Wrought Cobalt-chromium-molybdenum alloy,”

(iv) ISO 5833:1992 “Implants for Surgery—Acrylic Resin Cements,”

(v) ISO 5834-2:1998 “Implants for Surgery—Ultra-high Molecular Weight Polyethylene—Part 2: Moulded Forms,”

(vi) ISO 6018:1987 “Orthopaedic Implants—General Requirements for Marking, Packaging, and Labeling,” and

(vii) ISO 9001:1994 “Quality Systems—Model for Quality Assurance in Design/Development, Production, Installation, and Servicing,” and

(3) American Society for Testing and Materials':

(i) F 75-92 “Specification for Cast Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implant Material,”

(ii) F 648-98 “Specification for Ultra-High-Molecular-Weight Polyethylene Powder and Fabricated Form for Surgical Implants,”

(iii) F 799-96 “Specification for Cobalt-28 Chromium-6 Molybdenum Alloy Forgings for Surgical Implants,”

(iv) F 1044-95 “Test Method for Shear Testing of Porous Metal Coatings,”

(v) F 1108-97 “Specification for Titanium-6 Aluminum-4 Vanadium Alloy Castings for Surgical Implants,”

(vi) F 1147-95 “Test Method for Tension Testing of Porous Metal,”

(vii) F 1378-97 “Standard Specification for Shoulder Prosthesis,” and

(viii) F 1537-94 “Specification for Wrought Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implants.”

From 21 CFR 888.3660. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 888.3660 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent PHX clearances declared.

Ask about PHX

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about PHX

What is FDA product code PHX?

Product code PHX, “Shoulder Prosthesis, Reverse Configuration” in FDA's classification database, is a Class II device type under 21 CFR 888.3660 (shoulder joint metal/polymer semi-constrained cemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 206 clearances under PHX, 173 of them since 2011.

How many 510(k) clearances are there under PHX?

FDA’s 510(k) database listed 206 clearances under PHX as of Oct 29, 2026, 173 of them decided since 2011; the most recent decision was Oct 2, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a PHX 510(k)?

For the 27 PHX clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 128 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most PHX clearances?

Since 2011: Encore Medical L.P. (14), Exactech, Inc. (14), Medacta International S.A. (12), Arthrex, Inc. (11) and Biomet Manufacturing Corp (11). 39 applicants have cleared a PHX device in that time.

Sources

  1. FDA product classification: PHX · Product Classification database
  2. 21 CFR 888.3660: Shoulder joint metal/polymer semi-constrained cemented prosthesis · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for PHX · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow PHXGet an email when FDA clears, recalls or publishes guidance for PHX devices.

Know what FDA already cleared.